This 2018 Trends in Biotechnology review argues that nanoparticles (NPs) are a promising route to overcome the plant cellβwall barrier and broaden cargo types (DNA, RNA, proteins, RNPs), but it is cautious: most NP reports in plants were early, often required external assistance, and stable, speciesβwide, germline transformation remains unresolved
This single-column visual analysis focuses on (A) what the paper claims and supports, (B) evidence/data from the literature it uses, and (C) blind spots and practical next steps. Visuals first, then concise evidence-backed commentary with inline citations for every claim.
The review correctly collects multiple independent demonstrations where engineered NP properties (size, charge, aspect ratio, surface chemistry) enabled internalization or strong tissue uptake without full protoplastization: MSNs into Arabidopsis roots and gold-capped MSNs co-delivered DNA/chemicals via biolistic assistance (Torney et al.); CNT-based passive delivery to leaves and chloroplasts produced transient expression or silencing with high efficiencies in specific studies
In animal systems, NPs routinely deliver protein/RNP cargo including Cas9 RNPs with high editing efficiency and reduced off-targets. The review projects this potential to plants; published plant NP work has already delivered proteins and nucleic acids, but DNA-free genome editing in plants by NP-delivered RNPs remains early and mostly demonstrated in protoplast or assisted contexts
The authors correctly highlight that even with efficient somatic delivery, heritable edits depend on germline targeting or regeneration from transformed somatic tissueβprocedures that are species- and genotype-dependent and often rate-limiting for crops
Cunningham et al. bring attention to phytotoxicity reports (vascular blockage, oxidative stress, DNA damage) and the dose/species dependence of NP effects; subsequent literature continues to stress careful toxicology and environmental fate studies before field deployment
Cunningham et al. (2018) is a careful, forward-looking review that synthesizes promising early demonstrations (MSNs, CNTs, LDH, polymeric NPs) and frames nanoparticles as a plausible, highβutility platform to address plant delivery bottlenecks and to enable DNAβfree genome editing with nuclease cargos. Empirical support exists for NP-mediated transient delivery in several species/tissues, and for pollen magnetofection in one highβimpact report. However, general, reproducible passive delivery across tissues and species (especially germline) and comprehensive safety/ecosystem assessments were not yet established in 2018 and remain key open problems. The paper correctly prioritizes mechanistic work and cross-species optimization as the next steps and remains a valuable, evidenceβbased roadmap for the field
Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.